<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03151603</url>
  </required_header>
  <id_info>
    <org_study_id>01579</org_study_id>
    <nct_id>NCT03151603</nct_id>
  </id_info>
  <brief_title>Reducing Antibiotic Use for Uncomplicated Urinary Tract Infection in General Practice by Treatment With Uva Ursi (UU)- a Comparative Effectiveness Trial</brief_title>
  <acronym>REGATTA</acronym>
  <official_title>Reducing Antibiotic Use for Uncomplicated Urinary Tract Infection in General Practice by Treatment With Uva Ursi (UU)- a Comparative Effectiveness Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Center Goettingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medical Center Goettingen</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is well known that &quot;over-treatment&quot; of straightforward infections should be avoided as far
      as possible. Evidence-based data on non antibiotic treatment options for common conditions
      are therefore needed urgently. This randomised-controlled double blind trial examines whether
      initial herbal treatment with Uva Ursi, and antibiotic treatment only if symptoms persist,
      reduces antibiotic consumption in uncomplicated urinary tract infections (UTI) without a
      negative effect on symptom course and rate of recurrent UTIs. In total, 430 patients
      presenting with typical UTI symptoms will be included by their GPs and receive randomised
      either herbal treatment with uva ursi (antibiotics only if symptoms persist), or initial
      antibiotic treatment. Patients record symptom severity and drug intake in a diary and
      complete a final questionnaire after 28 days.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 3, 2017</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>antibiotic courses</measure>
    <time_frame>day 0-28</time_frame>
    <description>number of antibiotic courses from day 0 to day 28</description>
  </primary_outcome>
  <primary_outcome>
    <measure>symptom burden</measure>
    <time_frame>day 0-7</time_frame>
    <description>symptom burden (AUC) from day 0 to day 7</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>early relapses</measure>
    <time_frame>day 0-14</time_frame>
    <description>number of early relapses until day 14</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>recurrent UTI</measure>
    <time_frame>day 15-28</time_frame>
    <description>number of recurrent UTI day 15-28</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>symptom resolution</measure>
    <time_frame>day 4 and 7</time_frame>
    <description>number of patients with symptom resolution on day 4/7</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>symptom sum score by patients' questionnaire</measure>
    <time_frame>day 0-7</time_frame>
    <description>mean daily symptom sum scores from day 0 to day 7; Each of the symptoms dysuria, urgency, frequency and lower abdominal pain is scored daily on a five point scale from 0 &quot;none&quot; to 4 &quot;very strong&quot; in a patients' questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>symptom burden for dysuria</measure>
    <time_frame>day 0-7</time_frame>
    <description>symptom burden (AUC) for dysuria scored daily on a five point scale from 0 &quot;none&quot; to 4 &quot;very strong&quot;, from day 0 to day 7</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>symptom burden positive urine culture</measure>
    <time_frame>day 0-7</time_frame>
    <description>symptom burden (AUC) day 0-7 of patients with positive urine culture</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>symptom burden negative urine culture</measure>
    <time_frame>day 0-7</time_frame>
    <description>symptom burden (AUC) day 0-7 of patients with negative urine culture</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>activity impairment by UTI symptoms, measured as AUC</measure>
    <time_frame>day 0-7</time_frame>
    <description>activity impairment by UTI symptoms (days 0-7), measured as AUC. Impairment by each UTI symptom is scored daily on a five point scale from 0 &quot;none&quot; to 4 &quot;very strong&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>painkillers</measure>
    <time_frame>day 0-7</time_frame>
    <description>use of painkillers (Defined Daily Dose (DDD) day 0-7)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patients taking painkillers</measure>
    <time_frame>day 28</time_frame>
    <description>number of patients taking painkillers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>antibiotic use</measure>
    <time_frame>day 0-28</time_frame>
    <description>antibiotic use (defined daily dose (DDD) day 0-28)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>UTI related visits</measure>
    <time_frame>day 0-28</time_frame>
    <description>number of UTI related visits day 0-28</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>UTI related sick leave</measure>
    <time_frame>day 0-28</time_frame>
    <description>number of days of UTI related sick leave day 0-28</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patients with poor outcome: temperature</measure>
    <time_frame>day 0-7</time_frame>
    <description>number of patients with temperature &gt;38°C, day 0-7, according to patients´ statement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patients with poor outcome: worsening symptoms</measure>
    <time_frame>day 28</time_frame>
    <description>number of patients with worsening symptoms (impairment in symptom score)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patients with poor outcome: prolonged symptoms</measure>
    <time_frame>day 0-28</time_frame>
    <description>number of patients with prolonged symptoms (&gt; 7 days), day 0-28. Patients will be followed up until symptom resolution, defined as max. 1 score point on each symptom scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pyelonephritis</measure>
    <time_frame>day 0-28</time_frame>
    <description>number of pyelonephritis day 0-28, according to GP´s diagnosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AE and SAE</measure>
    <time_frame>day 0-28</time_frame>
    <description>number of AE and SAE by system organ class day 0-28</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patients with at least 1 AE/ 2 AE</measure>
    <time_frame>day 28</time_frame>
    <description>proportion of patients with at least 1 AE/ 2 AE</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>symptom burden for urgency</measure>
    <time_frame>day 0-7</time_frame>
    <description>symptom burden (AUC) for urgency scored daily on a five point scale from 0 &quot;none&quot; to 4 &quot;very strong&quot;, from day 0 to day 7</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>symptom burden for frequency</measure>
    <time_frame>day 0-7</time_frame>
    <description>symptom burden (AUC) for frequency scored daily on a five point scale from 0 &quot;none&quot; to 4 &quot;very strong&quot;, from day 0 to day 7</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>symptom burden for lower abdominal pain</measure>
    <time_frame>day 0-7</time_frame>
    <description>symptom burden (AUC) for lower abdominal pain scored daily on a five point scale from 0 &quot;none&quot; to 4 &quot;very strong&quot;, from day 0 to day 7</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">430</enrollment>
  <condition>Urinary Tract Infections</condition>
  <arm_group>
    <arm_group_label>Uva Ursi</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>placebo to fosfomycin: 3 g granules orally 1x1 (day 0)
and
Uva Ursi: 105 mg (Arctuvan®) 3x2 tablets orally from day 0 for 5 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>fosfomycin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>fosfomycin (Monuril®): 3 g granules orally 1x1 (day 0),
and
placebo to Uva Ursi: 3x2 tablets orally from day 0 for 5 days
If the patient returns with persistent/recurrent symptoms, antibiotic therapy according to the sensitivity test.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Arctuvan</intervention_name>
    <description>application of a herbal drug</description>
    <arm_group_label>Uva Ursi</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fosfomycin</intervention_name>
    <description>application of an antibiotic drug</description>
    <arm_group_label>fosfomycin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo to Arctuvan</intervention_name>
    <description>application of Placebo to Arctuvan</description>
    <arm_group_label>fosfomycin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo to Fosfomycin</intervention_name>
    <description>application of Placebo to Fosfomycin</description>
    <arm_group_label>Uva Ursi</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women (18-75 years) with suspected UTI

          -  at least two symptoms of UTI (dysuria, urgency of micturition, frequency, lower
             abdominal pain)

          -  Written informed consent

        Exclusion Criteria:

          -  signs of complicated UTI (e. g. temperature &gt; 38°C, loin tenderness)

          -  conditions that may lead to complicated infections (i.e. renal diseases, patients with
             urinary catheter)

          -  pregnancy/ breastfeeding

          -  current self-medication with UU preparations e.g. z.B. Cystinol®, Uvalysat®, Arctuvan®

          -  antibiotic use in the last 7 days

          -  previous UTI in the past 2 weeks

          -  history of pyelonephritis

          -  contraindications for trial drugs

          -  serious diseases

          -  inability to understand trial Information

          -  current participation in another clinical trial or participation in another clinical
             trial within the last 4 weeks
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eva Hummers-Pradier, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medical Center Göttingen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eva Hummers-Pradier, Prof. Dr.</last_name>
    <phone>+49 (0) 551</phone>
    <phone_ext>39-22638</phone_ext>
    <email>Eva.Hummers-Pradier@med.uni-goettingen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>ldikó Gágyor, Dr.</last_name>
    <phone>+49 (0) 551</phone>
    <phone_ext>39-14221</phone_ext>
    <email>igagyor@gwdg.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>General Practice Aden</name>
      <address>
        <city>Braunschweig</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ilka Aden, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Scheffer</name>
      <address>
        <city>Braunschweig</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephan Scheffer, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Coutelle</name>
      <address>
        <city>Bremen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Coutelle, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Schelp</name>
      <address>
        <city>Bremen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Holger Schelp</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Dickow</name>
      <address>
        <city>Burgwedel</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mona Dickow, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Kiwit-Putzer</name>
      <address>
        <city>Burgwedel</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dorothee Kiwit-Putzer, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Kutzsche</name>
      <address>
        <city>Emmerthal</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tina Kutzsche</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Müller</name>
      <address>
        <city>Gillersheim</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manfred Müller</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institute of General Medicine, University Medical Center Goettingen</name>
      <address>
        <city>Goettingen</city>
        <zip>37073</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eva Hummers-Pradier, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Keske</name>
      <address>
        <city>Göttingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wolfgang Keske, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Koch</name>
      <address>
        <city>Göttingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Koch, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Kolb</name>
      <address>
        <city>Göttingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabine Kolb</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Lang</name>
      <address>
        <city>Göttingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin A Lang, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Lückerath</name>
      <address>
        <city>Göttingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marianne Lückerath, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institute of General Medicine, MHH Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jutta Bleidorn, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Barth</name>
      <address>
        <city>Hannover</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monika Barth, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Löber</name>
      <address>
        <city>Hardegsen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthias Löber, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Wilde</name>
      <address>
        <city>Hildesheim</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elmar Wilde, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Beverungen</name>
      <address>
        <city>Höxter-Lüchtringen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Regina Beverungen, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Franz</name>
      <address>
        <city>Katlenburg-Lindau</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Uwe Franz, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Ertel</name>
      <address>
        <city>Langwedel</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthias Ertel</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Wehrbein</name>
      <address>
        <city>Lemforde</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dirk Wehrbein</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Lindenblatt</name>
      <address>
        <city>Neustadt</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reinhild Lindenblatt</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Preiskorn</name>
      <address>
        <city>Rehburg-Loccum</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Axel Preiskorn, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Meier-Ahrens</name>
      <address>
        <city>Rosdorf</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karin Meier-Ahrens, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Woitschek</name>
      <address>
        <city>Salzgitter</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beate Woitschek</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Beulshausen</name>
      <address>
        <city>Sattenhausen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hella Beulshausen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Schulte</name>
      <address>
        <city>Scheeßel</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Schulte, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Böttcher</name>
      <address>
        <city>Schwanewede</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susanne Böttcher</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Albrecht</name>
      <address>
        <city>Springe</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Albrecht, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Wolf</name>
      <address>
        <city>Uslar-Volpriehausen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Wolf, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Schmiemann</name>
      <address>
        <city>Verden</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guido Schmiemann, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Annweiler</name>
      <address>
        <city>Waake</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Uta Annweiler, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Practice Stegemann</name>
      <address>
        <city>Wunstorf-Luthe</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rolf Stegemann, Dr.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 10, 2017</study_first_submitted>
  <study_first_submitted_qc>May 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2017</study_first_posted>
  <last_update_submitted>June 2, 2017</last_update_submitted>
  <last_update_submitted_qc>June 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medical Center Goettingen</investigator_affiliation>
    <investigator_full_name>Karsten Gavenis</investigator_full_name>
    <investigator_title>Quality Assurance Staff Unit Clinical Trials</investigator_title>
  </responsible_party>
  <keyword>Uva Ursi</keyword>
  <keyword>fosfomycin</keyword>
  <keyword>uncomplicated urinary tract infection of women</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Urinary Tract Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Fosfomycin</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

